Metabolic consequences of interleukin-6 challenge in developing neurons and astroglia

Abstract

BackgroundMaternal immune activation and subsequent interleukin-6 (IL-6) induction disrupt normal brain development and predispose the offspring to developing autism and schizophrenia. While several proteins have been identified as having some link to these developmental disorders, their prevalence is still small and their causative role, if any, is not well understood. However, understanding the metabolic consequences of environmental predisposing factors could shed light on disorders such as autism and schizophrenia.MethodsTo gain a better understanding of the metabolic consequences of IL-6 exposure on developing central nervous system (CNS) cells, we separately exposed developing neuron and astroglia cultures to IL-6 for 2 hours while collecting effluent from our gravity-fed microfluidic chambers. By coupling microfluidic technologies to ultra-performance liquid chromatography-ion mobility-mass spectrometry (UPLC-IM-MS), we were able to characterize the metabolic response of these CNS cells to a narrow window of IL-6 exposure.ResultsOur results revealed that 1) the use of this technology, due to its superb media volume:cell volume ratio, is ideally suited for analysis of cell-type-specific exometabolome signatures; 2) developing neurons have low secretory activity at baseline, while astroglia show strong metabolic activity; 3) both neurons and astroglia respond to IL-6 exposure in a cell type-specific fashion; 4) the astroglial response to IL-6 stimulation is predominantly characterized by increased levels of metabolites, while neurons mostly depress their metabolic activity; and 5) disturbances in glycerophospholipid metabolism and tryptophan/kynurenine metabolite secretion are two putative mechanisms by which IL-6 affects the developing nervous system.ConclusionsOur findings are potentially critical for understanding the mechanism by which IL-6 disrupts brain function, and they provide information about the molecular cascade that links maternal immune activation to developmental brain disorders.Electronic supplementary materialThe online version of this article (doi:10.1186/s12974-014-0183-6) contains supplementary material, which is available to authorized users.

Metabolic consequences of inflammatory disruption of the blood-brain barrier in an organ-on-chip model of the human neurovascular unit

“…Ultraperformance liquid chromatography-ion mobility-mass spectrometry (UPLC-IM-MS) and data-independent MS acquisition with simultaneous analysis of molecular fragmentation (MS E ) were performed on a Waters Synapt G2 HDMS (Milford, MA, USA) mass spectrometer equipped with a Waters nanoAcquity UPLC system and autosampler (Milford, MA, USA), as previously described [39]. Metabolites were separated on a reverse phase 1 mm × 100 mm HSS T3 C 18 column packed with 1.8-μm particles (Waters, Milford, MA, USA) held at 45°C.…”

In Utero Exposure to Histological Chorioamnionitis Primes the Exometabolomic Profiles of Preterm CD4+ T Lymphocytes

“…Samples were prepared for reverse phase (C 18 ) IM-MS and analyzed as previously reported 27 and shown in Fig. S1b.…”

Human dermal fibroblasts in psychiatry research

“…Neurons have a narrow metabolic spectrum and rely on glia in almost every metabolic process (Brown et al, 2014; Lundgaard et al, 2014). Energy storage and supply and lipid homeostasis of the brain (fatty acid oxidation, cholesterol biosynthesis and trafficking) is primarily driven by astrocytes (Bélanger et al, 2011; Dietschy and Turley, 2004).…”

“…Prolonged neuroinflammation with glial involvement is a key step in the progression of multiple psychiatric diseases (Leonard, 2007; Müller et al, 2012). Consequently, altered expression of immune and cell-cell communication molecular pathways in HDFs from subjects with MD and SZ (Cattane et al, 2015; Garbett et al, 2015b), as well as BD specific changes in the basal and cytokine-induced tryptophan-kynurenine metabolism (Brown et al, 2014; Johansson et al, 2013a) may reflect disrupted glial inflammatory functions in the brains of diseased individuals.…”